Loading clinical trials...

Insulin Resistance in HCV Infection | Clinical Trials | Clareo Health

Active Not RecruitingNCT01858012

Insulin Resistance in HCV Infection

The study hypothesis is that the means by which HCV induces glucose intolerance is through impairment of B-cell function and compensatory hyperinsulinemia in predisposed Latinos with insulin resistanc...

Lead sponsor: University of California, San Francisco•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGNA

Artichoke By-products Rich in Hydroxycinnamic Acids and Mediterranean Diet for Type 2 Diabetes Prevention.

NCT07415720 · Diabete Type 2, Obesity & Overweight, and more

RECRUITINGNA

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes

NCT05543083 · Insulin Resistance, Depression, and more

RECRUITINGPhase 1

Effect of Insulin Lowering on Lipogenesis

NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more

RECRUITINGPhase 2

Efficacy and Safety of Oral Controlled-release Nicotinic Acid (CIR-NA) for the Remission of Prediabetes. (CONCEPT)

NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)

RECRUITING

Genetic Studies of Insulin and Diabetes

NCT00001987 · Diabetes Mellitus, Severe Insulin Resistance

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 10, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment250

Start dateJan 2008

Last updatedJun 10, 2025

Condition

Insulin Resistance

Locations shown

University of california San Francisco

San Francisco, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 10, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions